Compare SLGL & EFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLGL | EFT |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.1M | 291.3M |
| IPO Year | 2016 | 2004 |
| Metric | SLGL | EFT |
|---|---|---|
| Price | $75.40 | $10.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $110.00 | N/A |
| AVG Volume (30 Days) | 25.0K | ★ 70.5K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $223.84 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $10.34 |
| 52 Week High | $97.97 | $12.67 |
| Indicator | SLGL | EFT |
|---|---|---|
| Relative Strength Index (RSI) | 57.90 | 37.21 |
| Support Level | $66.48 | $10.65 |
| Resistance Level | $81.64 | $10.95 |
| Average True Range (ATR) | 6.76 | 0.08 |
| MACD | 0.83 | -0.02 |
| Stochastic Oscillator | 88.07 | 10.21 |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.